Regulation of transcription factors NFκB and AP‐1 following tumour necrosis factor‐α treatment of cells from chronic B cell leukaemia patients

No abstract is available for this paper.

• Publication year

  1994

• Venue

  British Journal of Haematology

• Publication date

  1994-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.1994.tb04779.x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The mitogenic response to tumor necrosis factor alpha requires c-Jun/AP-1

  1993cited by this paper
• A signal chain of events

  1992cited by this paper
• Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation.

  1992cited by this paper
• Signal transduction: the nuclear target.

  1992cited by this paper
• B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors.

  1992cited by this paper
• Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.

  1991cited by this paper
• Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.

  1991cited by this paper
• The AP-1 complex and its role in transcriptional control by protein kinase C

  1991cited by this paper
• CHAPTER 14 - Fos and Jun: intermediary transcription factors

  1991cited by this paper
• Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor.

  1990cited by this paper
• The relationship of chronic lymphocytic leukemia to normal activated B cells.

  1990cited by this paper
• Tumour necrosis factor signal transduction.

  1990cited by this paper
• Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.

  1990cited by this paper
• Protein kinase C-independent activation of nuclear factor kappa B by tumor necrosis factor.

  1990cited by this paper
• Expression of proto-oncogene c-jun during differentiation of B-chronic lymphocytic leukemia.

  1990cited by this paper
• Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia.

  1989cited by this paper
• A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence

  1989cited by this paper
• Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiate by TPA.

  1988cited by this paper
• Analysis of signal transduction in B chronic lymphocytic leukemia cells.

  1988cited by this paper
• Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

  1988cited by this paper
• Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor

  1988cited by this paper
• Effects of human interleukin 1 and human tumor necrosis factor on human T lymphocyte colony formation.

  1987cited by this paper
• Drastically increased expression of MYC and FOS protooncogenes during in vitro differentiation of chronic lymphocytic leukemia cells.

  1987cited by this paper
• Effect of tumor necrosis factor alpha on mitogen-activated human B cells

  1987cited by this paper
• Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors

  1986cited by this paper
• Rapid down‐regulation of protein kinase C and membrane association in phorbol ester‐treated leukemia cells

  1985cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia

  2024cites this paper
• Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role

  2020cites this paper
• NFkB is activated by multiple mechanisms in hairy cell leukemia

  2015cites this paper
• Intracellular cytokine expression in T cells from patients with chronic lymphocytic leukemia

  2013cites this paper
• leukemia Advances in the biology and treatment of B-cell chronic lymphocytic

  2011cites this paper
• TNF Polymorphisms Independently Predict Outcome in Patients with B-Cell Non-Hodgkin’s Lymphoma

  2009cites this paper
• Dendritic Cell and Macrophage-Mediated Tolerance in Lupus-Prone Mice

  2007cites this paper
• Mouse splenic B lymphocyte activation using different activation stimuli induces in vitro splicing of tumor necrosis factor-alpha nuclear pre-mRNA.

  2006cites this paper
• Production of intracellular IL‐2, TNF‐α, and IFN‐γ by T cells in B‐CLL

  2003cites this paper
• The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia

  2002cites this paper
• Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells

  2001cites this paper
• CD40 Ligand in CLL Pathogenesis and Therapy

  2000cites this paper
• Generation of patterns from gene expression data by assigning confidence to differentially expressed genes

  2000cites this paper
• Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: A new role for TNF alpha?

  2000cites this paper
• Cytokines and gynecological cancer.In vitro effects of cytokines on ovarian, endometrial and vulvar carcinoma cells

  2000cites this paper
• The cellular biology of B-cell chronic lymphocytic leukemia.

  1998cites this paper
• Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in chronic lymphocytic leukaemia

  1997cites this paper
• Defects in signal transduction pathways in chronic B lymphocytic leukemia cells.

  1995cites this paper
• Advances in the biology and treatment of B-cell chronic lymphocytic leukemia.

  1995cites this paper